Antitumor activity among derivatives of the 3-chloro-4-(3-hydroxyanilino) -2,5-dihydropyrrole-2,5-dione

Biopolymers and Cell

Volumn 19, Issue 6, 2003, Pages 548-552

  Tarnavsky, S S ^a   Dubinina, G G ^a   Golovach, S M ^a   Yarmoluk, S M ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67749134864     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.000682     Document Type: Article

References (4)

1. Fisher P. M., Lane D. P. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics // Cur. Med. Chem.-2000.-7.-P. 1213-1245.
2. Senderowicz A. M. The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01 // Oncologist.-2002.-12.-P. 12-19.
3. Bailly C, Qu X., Chaires J. B., Colson P., Houssier C, Ohkubo M., Nishimura S., Yoshinari T. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxyty, DNA binding, and topoisomerase I inhibition activities // J. Med. Chem.-1999.-42.-P. 2927.
4. Andricopulo A. D., Yunes R. A., Nunes R. J., Savi A. O. S., Correa R., Cruz A. B., Filho V. C. Synthesis and antibacterial activity of cyclic imides: 3,4-dichloromaleimides and 4-substituted 3-chloromaleimides // Quim. Nova.-1998.-21, N 5.-P. 573-577.